David A. Baran, MD

Personal Information

Education & Training

Education

Florida Atlantic University, Boca Raton, FL — Bachelor of Arts (Honors), Chemistry — 08/1984–05/1988

University of South Florida College of Medicine, Tampa, FL — MD — 08/1988–05/1992

Post-Graduate Training

Columbia-Presbyterian Medical Center, New York City, NY — Internal Medicine Categorical Residency — 07/1992–06/1995

Columbia-Presbyterian Medical Center, New York City, NY — Circulatory Physiology Research Fellowship (Mentor: Dr. Dan Burkhoff) — 07/1995–06/1996

Mount Sinai Medical Center, New York City, NY — Cardiovascular Diseases Fellowship — 07/1996–06/1998

Columbia-Presbyterian Medical Center, New York City, NY — Heart Transplant Training Fellowship (Mentor: Dr. Donna Mancini) — 07/1998–06/1999

Additional Career Development

Clinical Development

C3 Conference — Large Bore Access Training — 06/18/2018

Abiomed Inc — Impella Training Course — 06/19/2018

Professional Appointments

Section Head, Heart Failure, Transplant and Mechanical Circulatory Support — Cleveland Clinic, Heart Vascular and Thoracic Institute, Department of Medicine / Division of Cardiology, Weston, FL — 07/2022–Present

System Director, Advanced Heart Failure, Transplant and Mechanical Circulatory Support — Sentara Heart Hospital, Sentara Cardiology Specialists, Norfolk, VA — 08/2017–06/2022

Director, Heart Failure and Transplant Research — Newark Beth Israel Medical Center, Division of Cardiology, Newark, NJ — 07/2003–07/2017

Staff, Heart Transplant Team — Mt. Sinai Medical Center, Cardiovascular Institute, Department of Medicine, New York City, NY — 07/1999–06/2003

Academic Appointments

Professor, Department of Medicine — Cleveland Clinic Lerner College of Medicine — 08/2024–current

Adjunct Professor, Department of Medicine — Florida Atlantic University — 06/2024–current

Professor, Department of Medicine — Eastern Virginia Medical School, Norfolk, VA — 09/2017–02/2024

Clinical Associate Professor, Department of Medicine — Rutgers New Jersey Medical School, Newark, NJ — 07/2009–07/2017

Clinical Assistant Professor, Department of Medicine — Mt. Sinai School of Medicine, New York City, NY — 07/2003–07/2009

Assistant Professor, Department of Medicine — Mt. Sinai School of Medicine, New York City, NY — 07/2000–07/2003

Instructor, Department of Medicine — Mt. Sinai School of Medicine, New York City, NY — 07/1999–07/2000

Certification & Licensure

Board Certification

American Board of Internal Medicine, Internal Medicine — Certificate #162503 — 1995–Present

American Board of Internal Medicine, Cardiovascular Disease — Certificate #162503 — 1999, recertified–Present

American Board of Internal Medicine, Advanced Heart Failure and Transplant Medicine — Certificate #162503 — 2010–Present (recertified)

Medical Licensure

New York Board of Medicine — License #194832 — 1992–2003

New Jersey Board of Medicine — License #25MA07612700 — 2003–2017

Texas Board of Medicine — License #R2280 — 2017–2019

Virginia Board of Medicine — License #0101262619 — 2017–Present

Florida Board of Medicine — License #ME153917 — 2022–Present

Membership in Professional Societies

Fellow of the American College of Cardiology — 1997–Present

American Heart Association, Member, Clinical Cardiology Council — 1997–Present

International Society for Heart and Lung Transplantation, Member — 1998–Present

American Society of Transplantation, Member, former Executive Council Chair — 2006–Present

Fellow of the Heart Failure Society of America — 2010–Present

Fellow of the Society for Cardiac Angiography and Intervention — 2014–Present

Extracorporeal Life Support Organization, Member — 2019–Present

Professional Services

Editorial Board Membership

Journal of Heart and Lung Transplantation — 07/2017–Present

Section Editor, American Society for Artificial Internal Organs Journal — 05/2021–Present

Editorial Consultant, Journal of Cardiac Failure Intersections — 04/2025–Present

Editorial Consultant, Journal of the American College of Cardiology: Heart Failure — 06/2022–Present

Manuscript Reviewer

World Journal of Transplantation — 06/2012–05/2014

American Journal of Transplantation — 07/2014–Present

Transplant International — 01/2015–Present

Wound Repair and Regeneration — 02/2015–06/2015

American Journal of Cardiology — 05/2015–Present

Transplant Immunology — 01/2016–01/2020

Journal of the American College of Cardiology: Heart Failure — 02/2017–06/2022 (promoted to Editorial Consultant)

Journal of the American College of Cardiology: Cardiovascular Imaging — 01/2017–Present

Clinical Transplantation — 03/2017–Present

American Heart Journal — 01/2017–Present

Circulation — 04/2018–Present

Circulation: Heart Failure — 04/2018–Present

Transplantation — 04/2018–Present

Chest — 02/2019–Present

Journal of the American College of Cardiology: Interventions — 02/2019–Present

Pediatrics — 05/2019–Present

Journal of the American College of Cardiology — 09/2019–Present

Critical Care — 06/2020–Present

Experimental Gerontology — 07/2020–Present

European Society of Cardiology Heart Failure — 07/2020–Present

European Heart Journal — 08/2020–Present

Cardiac Failure Review — 01/2021–Present

Heart and Lung — 06/2021–Present

Grant Review Committees

American Medical Association — Reviewer, Medical Student Seed Grant Program — 01/2007–06/2008

Healthcare Analytics and Delivery Science Institute — Reviewer, Grants Committee — 01/2019–06/2022

Committee Service

International — International Society for Heart and Lung Transplantation (ISHLT)

Writing Committee, ISHLT Guidelines in Heart Transplantation, Member — 2008–2009

Heart Failure / Transplant Medicine Council, Chair — 2009–2010

Education Workforce, HF / Transplant Medicine Council, Chair — 2010–2014

Committee for HF / Transplant Medicine Core Competencies Academy (inaugural Academy in Heart Failure, ISHLT 2014, San Diego), Co-Chair — 2012–2014

Standards Guidelines Workforce, HF / Transplant Medicine Council, Chair — 2014–2016

Annual Meeting Program Committee, Group Leader (ISHLT Nice, France Meeting) — 2014–2015

Annual Meeting Program Committee, Group Leader (ISHLT Washington, DC Meeting) — 2015–2016

Education Committee, Advisors to ISHLT Board of Directors, Member — 2016–2019

Workforce to Revise the ISHLT Website, Member — 2016–2017

ISHLT Donor Heart Selection Task Force 1: Donor characteristics and their relationship to post-transplant outcomes, Co-Chair — 2018–2019

Mechanical Circulatory Support Guidelines, ISHLT Task Force 2, Member — 2019–2021

ISHLT Special Task Force on Cardiogenic Shock, Co-Chair — 2021–Present

Annual Meeting Program Committee, Mechanical Circulatory Support Group Leader (ISHLT Denver, CO Meeting) — 2022–2023

Annual Meeting Program Committee, Post-Heart Transplant Group Leader (ISHLT Prague, Czech Republic Meeting) — 2023–2024

Elected to the Board of Directors, International Society of Heart and Lung Transplantation — 3-year term, 2024–2027

Society for Cardiac Angiography and Intervention (SCAI)

Interventional Heart Failure Council, Member — 2014–2019

Clinical Expert Consensus Statement on the Classification of Cardiogenic Shock, Co-Chair — 2017–2019

SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training, Vice-Chair — 2020–2021

SCAI SHOCK Stages Classification Expert Consensus Update, Member — 2021–2022

SCAI SHOCK Stages Classification Expert Consensus 2025 Update, Co-Chair — 2025–2026

National — Cardiovascular Research Foundation

Clinical Events Committee, "Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in a Compassionate Use Registry", Member — 2002–2004

Clinical Events Committee, EMERALD Trial, Member — 2002–2004

Clinical Events Committee, EPI Trial, Member — 2002–2004

Clinical Events Committee, TERAMed/QUANTUM Trial, Member — 2002–2007

Clinical Events Committee, SECURE Trial, Member — 2002–2004

Clinical Events Committee, MATRIX Registry, Member — 2003–2007

Data Safety Monitoring Board, ICON Trial (Ionic vs. Non-ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients), Member — 2003–2007

Data Safety Monitoring Board, Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT Trial), Member — 2012–2015

Clinical Events Committee, PARACHUTE Trial, Member — 2012–2017

Other National / Industry

Invasive Monitoring Attenuation Through Gene Expression (IMAGE) Trial — Steering Committee, Member — 2008–2009

United Network for Organ Sharing — Membership and Professional Standards, Member at Large — 2013–2015

United Network for Organ Sharing — Organ Procurement Transplant Network Joint Society Working Group on Primary Surgeon / Physician Qualifications, Member — 2014–2015

American Society of Transplant — Thoracic Community of Practice, Executive Council, Member — 2014–2016

Journal of Heart and Lung Transplantation — Social Media Workforce Leader (founder) — 2015–2019

Luitpold Pharmaceutical Trial Group — Steering Committee, Member — 2016–2018

American Osteopathic Association — Advanced Heart Failure / Transplant Secure Exam Writing Committee, Member — 2019

Procyrion — Steering Committee, Member — 2020–Present

CareDx — SHORE Trial, Steering Committee, Member — 2020–Present

United Network for Organ Sharing — Cardiac Transplant National Committee, Region 11 Representative — 2020–2022

The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock) — Executive Committee, Founder and Chair — 2021–Present

Natera — DEFINE/DETECT Trial, Steering Committee, Member — 2021–Present

Hospital / Program

Newark Beth Israel Medical Center — Medical Executive Committee, Member — 2010–2012

Sentara Norfolk General Hospital — Heart Transplant Quality and Advisory Committee, Chair — 09/2017–09/2021

Sentara Norfolk General Hospital — Heart Transplant Program, Director — 07/2017–09/2021

Cleveland Clinic — Heart Failure / Heart Transplant / Mechanical Circulatory Support Program, Director — 06/2022–Present

Educational Committees

American Board of Internal Medicine — Heart Failure Self Assessment Program Module, Member — 2014–2018

American College of Cardiology — ACC Self Assessment Program, Advanced Heart Failure and Transplantation, Chapter Author — 2021–Present

Honors & Awards

University Scholar, College of Natural Science, Florida Atlantic University — 1988 — Award for outstanding scholarship in the class of 1988, College of Natural Science

Infectious Diseases Special Contribution, Tampa General Hospital — May 1992 — Designed ID consult database for the Department to allow tracking of patients seen in consult, enabling trend analysis and data collection for potential research projects

Letter of Commendation, Department of Medicine, Presbyterian Hospital — 1993 — Outstanding medical student teaching, based on confidential student evaluations

Elected to Fellowship, American College of Cardiology — 2000

Mt. Sinai Hospital Team Excellence Award — 2001 — Overall excellence of cardiac transplant team, shared by all members

Mentor — Fellow recipient of Abstract Travel Award, Transplant Summit 2005: Defining the Future, San Francisco, October 26–28, 2005

Mentor — Fellow recipient of Abstract Travel Award, Transplant Summit 2007: Defining the Future, Chicago, October 23–25, 2007

Mentor — Fellow recipients of Travel Grant Award, AST Fellow in Transplant Training Seminar, Grapevine, Texas — October 2009, 2010, 2011, 2012, 2013

Elected to Fellowship, Society for Cardiac Angiography and Intervention — May 2014

Elected to Fellowship, Heart Failure Society of America — May 2019

"Top Doc," Coastal Virginia Magazine — 2019–2020 (Cardiology division)

Teaching Activities

Curriculum / Course Development

Design of ACGME curriculum for Advanced Heart Failure and Transplant Medicine Fellowship, Newark Beth Israel Medical Center — 06/2012–01/2013 — 150 hours; successful accreditation granted

Invited Lectures — International

2nd European Investigator's Workshop on Tacrolimus in Thoracic Transplantation, "Tacrolimus Monotherapy: Intermediate Term Results", Munich, Germany — 09/2000

Invited Lecture, "Results of the Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC) Trial", The Transplant Society, Berlin, Germany — 07/2012

Invited Lecture, "Right Heart Failure, Quo Vadis", Newcastle MCS Annual Symposium, Newcastle upon Tyne, United Kingdom — 10/2017

Invited Lecturer, 8th Annual Newcastle Advances in Mechanical Circulatory Support, Newcastle upon Tyne, United Kingdom — 12/2018

Invited Lecture, European Union Mechanical Support Symposium (EUMS), "Cardiogenic shock the unsolved challenge", Vienna, Austria — 12/2019

Grand Rounds, Western Ontario University, "Cardiogenic Shock: The Toolbox of 2020", London, Ontario — 01/2020

Invited Lecture, "Fifth International Conference in Heart Failure and Pulmonary Hypertension in the Polypharmacy and Device Era in Latin America" (Argentina, Virtual), "Cardiogenic Shock: Where Are We at the End of 2020?" — 12/2020

Invited Lecture, ISHLT Cardiology Professional Community Town Hall, "Cardiogenic Shock: SCAI Classification" — 01/2021

Webinar, ISHLTv "Around the World of Cardiogenic Shock: Interdisciplinary Research and Education", International Society for Heart and Lung Transplantation — 08/2021

Invited Lecturer, 30th Annual Argentinian Cardiovascular Surgery Meeting (Virtual), "Cardiogenic Shock Risk Stratification and Latest Insights" — 12/2021

Invited Lecturer (Virtual), Western Ontario University, "Cardiogenic Shock: Current Updates", London, Ontario — 01/2022

Invited Lecturer (Virtual), Cleveland Clinic Abu Dhabi, "Out of Hospital Cardiac Arrest: What are Best Practices?" — 08/09/2022

Invited Lecturer, European Association for Cardiothoracic Surgery, "Temporary MCS as a Bridge to Transplant", Berlin, Germany — 11/18/2022

Invited Lecturer, 31st Annual Argentinian Cardiovascular Surgery Meeting (Virtual), "Cardiogenic Shock Risk Stratification and Latest Insights" — 12/2022

Invited Lecturer, Society for Critical Care Medicine Annual Meeting, "Reach for the SCAI: Cardiogenic Shock Risk Stratification", San Francisco — 01/21/2023

Invited Lectures — National

Invited Lecturer, National Association of Transplant Coordinators Organization (NATCO), "Tacrolimus and Cardiac Transplantation: Less is More", New Orleans — 07/2003

Invited Lecture, "Status of Induction Therapy and Steroid Sparing Regimens", Transplant Summit: Defining the Future 2007, Chicago, IL — 09/2007

Invited Lecture, Heart Rhythm Society, St. Jude Sponsored Course, "Heart Failure 2012: A Tale of Drugs and Tin Men" — 05/2012

Invited Speaker, Heart Failure Society of America, "Beyond Drugs: ECMO, Impella or Nothing" — 09/2016

Invited Lecturer, Cutting Edge of Transplantation, American Society of Transplantation, Phoenix, AZ — 02/2016

Invited Lecture / Moderator, American College of Cardiology Meeting, "Short-Term Mechanical Support In Cardiogenic Shock… So Many Devices", Washington, D.C. — 03/2017

Invited Lecture / Moderator, American College of Cardiology Meeting, "Treating Cardiogenic Shock: Challenging Cases and Complications", Washington, D.C. — 03/2017

Invited Lecturer / Organizer / Moderator, SCAI Town Hall on Cardiogenic Shock (develop consensus with invited audience participants), at American College of Cardiology Meeting, Washington, D.C. — 03/2017

Invited Lecture / Moderator, American College of Cardiology Meeting, "Immunosuppression 101", Washington, D.C. — 03/2017

Invited Lecture, Tandem Heart System: ECMO Applications, ELSO Annual Meeting, Baltimore, MD — 09/2017

Invited Lecture, "Interventional Heart Failure: Devices for Shock", Cedars-Sinai Practicum on Mechanical Circulatory Support, Los Angeles, California — 10/2017

Invited Lecture, "Cardiogenic Shock: The Role of IABP", Transcatheter Therapeutics (TCT) Annual Meeting Faculty, Denver, Colorado — 10/2017

Invited Lecture, "Bridging with Percutaneous Devices — Tandem Heart and Impella", AATS 21st Century State of the Art Treatment of Advanced Heart Failure with Mechanical Circulatory Support, Houston, Texas — 03/2018

Invited Lecture, "Cardiogenic Shock: Devices and Outcomes", Inaugural Houston Shock Symposium, Memorial Hermann Medical Center, Houston, Texas — 04/2018

Invited Moderator and Lecturer, SCAI, "Treating Cardiogenic Shock: Hold, Fold or Send?" — 04/2018

Invited Moderator and Lecturer, SCAI, "ECPR — Crashing onto Support: Devices and Protocols" — 04/2018

Invited Moderator and Lecturer, SCAI, "Interventional Heart Failure: A New Pathway" — 04/2018

Invited Lecturer, "Future Leaders in Heart Failure Symposium", Heart Failure Society of America, Charlotte, North Carolina — 05/2018

Invited Lecturer, Heart Failure Society of America, Nashville, Tennessee — 09/2018

Invited Lecturer, Transcatheter Therapeutics (TCT) Congress, San Diego, California — 09/2018

Faculty Invited Lectures, Houston Shock Symposium, Houston, Texas — 03/2019

Invited Lecturer, Georgia STEMI Summit, Atlanta, Georgia — 03/2019

Invited Lecturer, International Society for Heart and Lung Transplantation (ISHLT), Orlando, Florida — 04/2019

Faculty Invited Lecture, HFSA Future Leaders Symposium, Washington, DC — 05/2019

Invited Lecturer, Society for Cardiac Angiography and Intervention, Annual Meeting, Las Vegas, Nevada — 05/2019

Invited Lecturer, American Society of Transplantation — 06/2019

Invited Lecturer, SCAI Shock 2nd Annual Meeting, Boston, Massachusetts — 09/2019

Invited Lecturer, Extracorporeal Life Support Organization (ELSO) meeting, Austin, Texas — 09/2019

Invited Lecturer, Heart Failure Society of America, Boston, Massachusetts — 09/2019

Invited Lecturer and Discussant, TransCatheter Therapeutics (TCT) meeting, San Francisco — 09/2019

Invited Lecture, Utah Cardiac Recovery Symposium (UCARS), "Shock Severity SCAI Classification: How to 'Identify, Communicate and Predict' in the Middle of the Shock Hurricane", Salt Lake City, Utah — 01/2020

Invited Lecture, Critical Care Clinical Trialists Workshop, "Which Severity of Cardiogenic Shock (SCAI Shock)?", Washington, DC — 02/2020

Invited Lecture, Critical Care Clinical Trialists Workshop, "Ethics issues in trials", Washington, DC — 02/2020

Invited Faculty, Houston Shock Conference, Houston, Texas — 03/2020

Invited Lecturer (Virtual), SCAI Conference, "Managing Cardiogenic and Combined shock in COVID patients" — 05/2020

Invited Lecturer (Virtual), Florida Chapter American College of Cardiology, "Understanding the data for temporary MCS: A debate that can't go away" — 08/2020

Invited Lecturer (Virtual), Acute Cardiopulmonary Shock Conference, Topic: TandemHeart and Tandemlife — 08/2020

Invited Lecturer (Virtual), Heart Failure Society of America 2020 Virtual Conference, "Challenges in Defining and Classifying Cardiogenic Shock: Why is it Important to Speak a Common Language?" — 10/2020

Invited Lecturer (Virtual), SCAI SHOCK Virtual Symposium, "Is IABP Appropriate as a First Line or Stabilization Tool?" — 10/2020

Invited Lecture, New York University Heart Failure Symposium, "Cardiogenic Shock: Classification and Treatment" — 05/2021

American Transplant Congress (Virtual), "What Do You Mean? Cardiogenic Shock Classification and Practical Applications" — 06/2021

Critical Care Clinical Trialists (3CT) Workshop (Virtual), Session Chair, "Definition of Refractory Cardiogenic Shock" — 07/2021

Invited Lecturer (Virtual), Extracorporeal Life Support Organization, "Redefining our Definitions: SCAI Staging System" — 09/2021

Invited Lecturer (in person), SCAI Fall Fellows Course, "Pro's and Cons of MCS" — 12/2021

Invited Lecturer (Virtual), Technology in Heart Failure Therapeutics (THT) Inaugural Meeting, New York City, "3IVE: 'Renal Puller' Mechanism of Action" — 02/2022

Invited Lecturer (Virtual), THT Inaugural Meeting, New York City, "Interventional Heart Failure from the Perspective of a Heart Failure Physician" — 02/2022

Invited Lecturer (Virtual), THT Inaugural Meeting, New York City, "How Sick Is My Patient? Risk Stratification in Cardiogenic Shock" — 02/2022

Invited Lecturer / Panelist, 4th Annual Houston Shock Conference, "Pitfalls of Shock Classification", Houston, TX — 03/2022

Invited Lecturer (Virtual), American Association of Heart Failure Nurses, "MCS Bootcamp: The SCAI is falling — understanding the Shock Pyramid, Classification and patient trajectory" — 09/16/2022

Invited Lecturer (Virtual), ACTION Pediatric Heart Transplant Society, "Bridging to Transplant: ECLS, tMCS: Pitfalls, Pearls and Perspectives" — 12/08/2022

Invited Lecturer (Virtual), "Shock Week: Debate on intensity of support for Cardiogenic Shock: PRO — Go Big or Go Home" — 01/21/2023

Invited Lecturer, Utah Cardiac Recovery Symposium, "Cardiogenic Shock: Everything works and nothing works" — 02/09/2024

Invited Lecturer, TCT Meeting, "Cardiogenic Shock: Everything works and nothing works" — 02/09/2024

Invited Lectures — Regional / Eastern

Invited Lecture, "Transplant with Minimal Immunosuppression", Transplant Society of New Jersey, Newark, New Jersey — 05/2005

Invited Lecturer, "Heart Failure and Implantable Cardiac Devices: Mechanism of Heart Failure", American Association of Critical Care Nurses, Morristown, New Jersey — 01/2006

Invited Lecture, "Heart Transplant Immunosuppression: Lessons Learned", Henry Ford Medical Center, Detroit, Michigan — 10/2011

Series of Lectures, National CME Heart Transplant Lecture Series, "Care of the Post-Cardiac Transplant Patient" — 2011 (Wycoff Hospital NY; Mary Washington Hospital Virginia; Jefferson Medical Center, Philadelphia)

Invited Lecturer, University of Miami School of Medicine — 10/2017

Invited Lecture, Westchester Cardiovascular Symposium, "Interventional Heart Failure: A New Subspecialty?", Westchester, NY — 10/2017

Grand Rounds, Stony Brook University Hospital, "Pulmonary Arterial Hypertension and the Right Ventricle: Latest Insights", Stony Brook, NY — 05/2018

Webinar, Virginia Cardiac Services Quality Initiative / Virginia Heart Attack Coalition, "Not All Shock is the Same: Definitions and Nomenclature" — 09/2021

Invited Lecture (Virtual), Massachusetts General Hospital Advanced Heart Failure Rounds, "The deceptively simple problem of cardiogenic shock" — 10/2021

Invited Keynote Lecturer (Virtual), Mt. Sinai Advances in Heart Failure Symposium, "Contemporary Management of Cardiogenic Shock" — 01/2022

Invited Lecturer (Virtual), University of Vermont, "Contemporary Management of Cardiogenic Shock" — 04/2022

Transplant Grand Rounds, Cleveland Clinic, "Immunosuppression in Heart Transplantation: Less is More" — 11/10/2022

Cardiology Grand Rounds, University of Florida Jacksonville Campus, "Cardiogenic Shock" — 01/13/2023

Invited Lecturer, Miami Valves Conference 2023, "Evolution of Cardiogenic Shock" — 02/02/2023

Invited Lectures — Local

Invited Lecturer, Newark Beth Israel Medical Center Internal Medicine Grand Rounds, "Heart Failure 2003 Update" — 07/2003

Cardiothoracic Surgery Invited Lecturer, "Immunosuppression: What Do We Really Know?", Westchester County Medical Center, Westchester, New York — 10/2005

Invited Lecture, "Heart-Kidney Transplantation: A View From Above the Diaphragm", Newark Beth Israel Medical Center — 10/2012

Invited Lecture, "Critical Care Cardiology: Acute Heart Failure", American Association of Indian Physicians, Jersey City, NJ — 06/2013

Invited Lecturer, Robert Wood Johnson Medical Center, Respiratory Conference — 10/2016

Invited Lecture, "Heart Failure Update", Sentara All Provider Annual Meeting, Virginia Beach, VA — 10/2017

Invited Lecture, "Heart Transplants and Donor Selection", Lifenet Health, Richmond, VA — 01/2018

Grand Rounds, Sentara Heart Hospital, "Cardiogenic Shock: Management of Crash and Burn", Norfolk, Virginia — 04/2018

Invited Lecture, "Cardiogenic shock and the Shock Team Approach", Sentara CarePlex Hospital, Newport News, VA — 10/2019

Speaker, Inaugural Tidewater Cardiogenic Shock Club, Virginia Beach, VA — 11/2019

Invited Lecture, Eastern Virginia Medical School Heart Club, "Heart in the Box" — 10/2021

Grand Rounds — Regional / Eastern

Transplant Grand Rounds, "Cardiac Transplantation: A Focus on Immunosuppression", Hartford Hospital, Hartford, Connecticut — 08/2002

Invited Lecture, "CHF: Primary Care Update", University of Alabama, Huntsville, Alabama — 10/2002

Invited Lecture, "Immunosuppression and Cardiac Transplantation", University of North Carolina Medical Center — 10/2003

Cardiology Grand Rounds, "Heart Transplant Immunosuppression", Duke University Medical Center, Durham, North Carolina — 03/2004

Cardiology Grand Rounds, "Heart Transplant Immunosuppression: New Insights", Lankenau Hospital, Philadelphia, PA — 04/2005

Cardiology Invited Lecture, "Heart Transplant Immunosuppression: New Insights", Temple University Hospital, Philadelphia, PA — 04/2005

Lecturer / Moderator, Liberty Health Systems Annual Cardiovascular Conference, NJ Performing Arts Center, Newark, New Jersey — 06/2006

Cardiac Transplant Grand Rounds, "Update in Heart Transplantation", Yale University, New Haven, Connecticut — 09/2006

Invited Lecturer, "Immunosuppression: What Do We Really Know?", Carolinas Medical Center, North Carolina — 10/2006

Invited Lecture, "Immunosuppression: What Do We Really Know?", Transplant Society of New Jersey, Springfield, NJ — 02/2007

Invited Lecture, "Immunosuppression: What Do We Really Know?", Transplant Academia, Duke University Medical Center — 05/2007

Invited Lecture, "Immunosuppression: What Do We Really Know?", Transplant Grand Rounds, University of North Carolina, Chapel Hill — 05/2007

Invited Lecture, "Heart Failure: Drugs and Devices", Liberty Health Systems Annual Cardiovascular Conference, NJ Performing Arts Center, Newark, NJ — 06/2007

Invited Lecture, "Right Ventricular Failure", American Association of Critical Care Nursing, Fairfield, NJ — 06/2007

Invited Lecture, "Heart Failure Update 2007", Pri-Med Institute, White Plains, NY — 09/2007

Invited Lecture, "Hearts for the Heartless: Heart Transplant and VADs", American Association of Critical Care Nurses Options Conference, New Brunswick, NJ — 03/2010

Invited Lecture, "Donor Crisis", LiveON Organ Procurement Organization Conference, New York City, NY — 11/2015

Donald Drew Memorial Lectureship, "Lost In Space: Heart Transplantation in the 21st Century", Eastern Virginia Medical School, Norfolk, VA — 01/2018

Invited Lecture (Virtual), Stony Brook University Medical Center Grand Rounds, "Cardiogenic Shock: Does Anything Work in 2020?" — 12/2020

Grand Rounds — Local

Professor's Rounds, "Update in Congestive Heart Failure", Englewood Hospital, Englewood, New Jersey — 11/1999

Cardiology Grand Rounds, "Congestive Heart Failure Case Studies: What Would You Do?", Mt. Sinai Hospital, New York City, NY — 06/2000

Cardiology Grand Rounds, "Congestive Heart Failure: Latest and Greatest in 2001", Northshore-Long Island Jewish Health System — 07/2001

Internal Medicine Grand Rounds, "Congestive Heart Failure 2002: Case Presentation and Management Approach", Mount Sinai Medical Center, New York City, NY — 08/2002

Internal Medicine Grand Rounds, "Heart Failure 2003: New Challenges", Lincoln Hospital, Bronx, New York City, NY — 01/2003

"Tacrolimus and Cardiac Transplantation: New Insights", Westchester County Medical Center, Westchester, New York — 02/2003

Invited Lecturer, Newark Beth Israel Medical Center, "High Tech, High Touch Symposium", Newark, New Jersey — 10/2003

Invited Lecturer, Second Annual Heart Institute of Staten Island Cardiac Symposium, Staten Island, NY — 11/2003

Internal Medicine Grand Rounds, "Heart Failure 2004", Harlem Hospital, New York City, NY — 04/2004

Internal Medicine Grand Rounds, "CHF Update", Mountainside Hospital, Mountainside, New Jersey — 06/2004

Internal Medicine Grand Rounds, "Heart Failure Update", St. Clare's Hospital, Denville, NJ — 01/2005

Internal Medicine Grand Rounds, "Heart Failure 2005", Somerset Medical Center, Somerset, New Jersey — 09/2005

Medical Resident Rounds, "Heart Failure: Diagnosis and Treatment", Christ Hospital, Jersey City, NJ — 09/2005

Internal Medicine Grand Rounds, "Heart Failure, Drugs and Devices", Morristown Memorial Hospital, Morristown, New Jersey — 05/2006

Internal Medicine Grand Rounds, "Heart Failure 2006 Update", St. Michael's Medical Center, Newark, NJ — 09/2006

Cardiology Grand Rounds, "Heart Failure, Drugs and Devices", White Plains Hospital Center, White Plains, NY — 10/2006

Cardiology Grand Rounds, "Heart Failure, Drugs and Devices", Cabrini Medical Center, New York City, NY — 10/2006

Cardiology Grand Rounds, "Heart Failure, Drugs and Devices", St Joseph's Medical Center, Patterson, NJ — 10/2006

Infectious Disease Fellow's Lecture, "Cardiac Transplantation", Newark Beth Israel Medical Center, Newark, New Jersey — 05/2007

Invited Lecture, "Heart Failure: Drugs and Devices", Monmouth Medical Center, Monmouth, New Jersey — 06/2007

Medical Grand Rounds, "Heart Failure 2009: A Tale of Drugs and Tin Men", Trinitas Hospital, Elizabeth, NJ — 08/2009

Medical Grand Rounds, "Heart Failure 2009: A Tale of Drugs and Tin Men", Mountainside Hospital, Montclair, NJ — 05/2009

Medical Grand Rounds, "Heart Failure 2011: A Tale of Drugs and Tin Men", Valley Hospital, Ridgewood, NJ — 03/2011

VACVPR Speaker, "Heart Failure Update 2019", Portsmouth, Virginia — 05/2019

Visiting Professorships

"Advanced Heart Failure and Cardiac Transplantation", Silesian Center for Heart Disease, Zabrze, Poland — 09/2002

Cardiology Grand Rounds / Visiting Lecturer, University of California, Los Angeles — 08/2016

Cardiology Grand Rounds / Visiting Lecturer, Stanford University — 01/2016

Other Presentations — International

Lecture, "Selection for Cardiac Transplantation", Polish Congress of Cardiology, Poznan, Poland — 09/2002

Panelist, "Advanced Cardiac Failure and Transplantation Session", Polish Congress of Cardiology, Poznan, Poland — 09/2002

Invited Chair, ISHLT Sunrise Symposium, "Immunobiology for the Clinician", San Francisco — 04/2007

Other Presentations — National

Invited Member, Consensus Conference: Critical Care in Thoracic Transplantation (Chair: Dr. Jon Kobashigawa), Seattle, Washington — 06/2018

Invited Moderator, American Transplant Congress, Seattle, Washington — 06/2018

Webinar Moderator, American Society for Transplantation: Role of VV and VA ECMO (Dr. Francis Pagani presenting) — 05/01/2019

Invited Panelist (Virtual), SCAI Conference — 05/2020

Invited Participant, Forum on Outcome Measures in Thoracic Transplantation (Chair: Dr. Jon Kobashigawa) — 11/2020

Invited Lecture, Medscape Going Back to the Heart of Cardiology 2020, "AMI Cardiogenic Shock: Real World Insights" — 12/2020

Webinar, SCAI Cardiogenic Shock First Prospective Validation, Docmatter.com — 05/2021

SCAI Shock Conference — Chair and Moderator for Session "Focus on Non-Ischemic Shock" — 10/2021

Invited Moderator, TransCatheter Therapeutics Meeting (TCT), "Cardiogenic shock session" — 11/2021

Other Presentations — Regional / Eastern

Duke University Transplant Academia, "Tacrolimus In Cardiac Transplantation: Less Is More", Durham, North Carolina — 10/2002

Invited Lecture, "CHF: Beyond Triple Therapy", Modern Therapeutics 2002, Huntsville, Alabama — 10/2002

Webinar, SCAI "So you Want to Start an ECMO Program?", Chair, South Atlantic Cardiovascular Society — 07/2021

Other Presentations — Local

Taussig-Bing Anomaly: Case Discussion and Literature Review, University of South Florida, Tampa, Florida — 04/1991

Tuberculous Pericarditis, Tampa General Hospital, Tampa, Florida — 01/1992

Delta Hepatitis, James A. Haley Veteran's Affairs Medical Center, Tampa, Florida — 04/1992

Endocarditis for the Medical Consultant, Columbia Presbyterian Medical Center, New York, NY — 12/1994

Cardiac Transplantation: From Azathioprine to Zenapax, Columbia-Presbyterian Medical Center, New York, NY — 04/1999

Cardiac Transplantation: A Fellow's Guide, Mt. Sinai Hospital, New York City, NY — 05/2000

Panelist, "What Causes the Progression of Heart Failure?", Mt. Sinai Hospital, New York City, NY — 03/2000

Transplant Rounds, "Tacrolimus: A User's Guide", Columbia Presbyterian Medical Center, New York City, NY — 01/2001

Lecture, "Cardiac Transplantation: An Internist's Guide", Lutheran Hospital, Brooklyn, NY — 03/2001

Controversies in Cardiology (Simon Dack Visiting Professorship): "Treatment of Concomitant Conditions in patients with Heart Failure", Mt. Sinai Medical Center, New York City, New York — 11/2002

Core Curriculum, Mount Sinai Cardiology Fellowship Lecture, "Cardiac Transplant: A Fellows Guide", Mt. Sinai Medical Center, New York City, New York — 12/2002

Panelist, "Neurological Considerations in Anticoagulant Therapy", Mount Sinai Neurosurgery Grand Rounds, Mt. Sinai Medical Center, New York City, NY — 05/2003

Trainees / Mentees

Saad Alvi, MD — 07/2004–07/2005 — Director Internal Medicine Clerkship, Weis Memorial Hospital, Chicago, IL

Mamata Alwarshetty, MD — 07/2005–06/2006 — Fellowship in Cardiology at Rush Presbyterian Medical Center; Practicing Interventional Cardiologist

Sangeetha Balasubramanian, MD — 07/2006–06/2007 — Rheumatologist, University of Massachusetts, Worcester, MA

Anand Pillai, MD — 07/2007–06/2008 — Cardiology training at Montreal Heart Institute; currently Cardiologist in home state in India

Arun Patil, MD — 07/2007–06/2008 — Practicing Cardiology, Westchester Medical Center, Westchester, NY

Rajiv Tayal, MD — 07/2009–10/2010 — Interventional Cardiologist, Catheterization Lab Director, Valley Hospital, New Jersey

Harsha Nagarajarao, MD — 07/2009–06/2010 — Interventional Cardiologist, Fort Wayne, Indiana

Janice Pieretti, MD — 07/2010–06/2011 — Director, Cardiac Amyloid Program, Hospital of the University of Pennsylvania

Cesar Guerrero, MD — 07/2010–06/2012 — Heart Failure / Transplant Cardiology, Director MCS Program, Baylor University Medical Center, Dallas, TX

Jeffrey Weiss, MD — 07/2012–06/2013 — Hospitalist, New Jersey

Abhishek Jaiswal, MD — 07/2013–06/2014 — Heart Failure / Transplant Cardiology, Hartford Hospital, Hartford, CT

Aleksandar Adzic, MD — 07/2013–06/2014 — Heart Failure / MCS, Maimonides Hospital, Brooklyn, NY

Jaime Hernandez-Montfort, MD — 07/2014–06/2015 — Executive Director, Advanced Heart Failure, Baylor Scott and White Hospital, Round Rock, Texas

Pavittarpaul Dhesi, MD — 07/2014–06/2015 — Critical Care Intensivist, Kaiser Permanente Los Angeles, CA

Khurram Liaquat, MD — 07/2015–06/2016 — Interventional Cardiologist

Saurabh Kapoor, MD — 07/2016–06/2017 — Transplant Program Director, Newark Beth Israel Medical Center, Newark, New Jersey

Teaching Material Produced

Course Director, Heart of the City Cardiovascular Symposium — 09/2018, Norfolk, Virginia — Audience: Physicians, Nursing, Students; Regional attendance > 250 people

Course Director, Heart of Battle Cardiovascular Symposium — 10/2019, Norfolk, Virginia — Audience: Physicians, Nursing, Students; Regional attendance > 250 people

Teaching Administration

Course Director, Advanced Heart Failure / Transplant Medicine Fellowship (not accredited) — 07/2004–06/2012

Fellowship Director, ACGME Certified Advanced Heart Failure and Transplant Medicine Fellowship — 07/2012–06/2016

Advanced Heart Failure / Transplant Medicine topics. Periodic 1-hour lectures to rotating residents in the Advanced Heart Failure rotation (from Eastern Virginia Medical School Residents and Students), typically 2 hours per month — 08/2017–09/2021

Research / Grant Support

Grant Supported

Cleveland Clinic Heart Vascular and Thoracic Institute Research Grant — VANQUISH Registry — Prospective registry of cardiogenic shock patients, collecting demographics, mortality, quality of life, and biomarkers — PI — 10% effort — $40,000 direct — 06/2022–06/2024

Astellas Pharmaceuticals — OneTac Trial (Investigator-initiated trial of Astagraf [tacrolimus modified release] in heart transplant recipients) — PI — 10% effort / 10% salary — $325,000 direct — 2015–2018

National Institutes of Health Subcontract — CTOT-18: An observational study of alloimmunity in cardiac transplant recipients from transplantation to one year (long-term extension) — PI — 5% effort — $50,000 direct — 2015–2016

Novartis Pharmaceuticals — ASTRONAUT: Multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate 6-month efficacy and safety of aliskiren therapy after hospitalization for acute decompensated heart failure — Co-PI — 5% effort — $6,722/patient — 2011–2012

Cardioxyl Pharmaceutical — CXL-1020: Phase IIa, 3-strata dose-defining study evaluating hemodynamic effect, safety, and tolerability of CXL-1020 in patients with systolic heart failure — PI — 5% effort — $10,000 direct — 2010–2012

Terumo Inc — DuraHeart™ LVAS: Evaluation of safety and effectiveness of the DuraHeart left ventricular assist system in patients awaiting transplantation — Co-PI — 5% effort — 2009–2011

Acorn Cardiovascular — Clinical evaluation of Acorn Cardiac Support Device therapy in patients with dilated cardiomyopathy (confirmatory trial) — Co-PI — 5% effort — 2008–2011

National Institutes of Health Subcontract — CTOT-05: An observational study of alloimmunity in cardiac transplant recipients from transplantation to one year — PI — 5% effort — $150,000 direct — 2008–2011

XDX Expression Diagnostics Inc — IMAGE Trial (Invasive Monitoring Attenuation Through Gene Expression): Multicenter trial comparing heart biopsy to biomarkers — PI — 5% effort — $9,195/patient — 2008–2011

Ventracor Inc — VentrAssist LVAD Pivotal Trial: Bridge to cardiac transplantation or destination therapy — Co-PI — 5% effort — $10,855/patient — 2008–2011

Duke Clinical Research Institute — ASCEND: Double-blind, placebo-controlled, multi-center acute study of clinical effectiveness of nesiritide in subjects with decompensated heart failure — PI — 5% effort — $7,000/patient — 2007–2011

Thoratec Corporation — HeartMate II Pivotal Trial: Multicenter ventricular assist device clinical trial — Co-PI — 5% effort — $8,000/patient — 2006–2009

Gilead Sciences — ARIES-3: Phase III, long-term, open-label, multicenter safety and efficacy study of ambrisentan in subjects with pulmonary hypertension — Co-PI — 5% effort — $8,936/patient — 2007–2009

Cothera/Novartis — RELAX-HF: Phase II/III, multicenter, randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of Relaxin in patients with acute heart failure — Co-PI — 5% effort — 2010–2012

Heartware Inc — ENDURANCE: Prospective, randomized, controlled, multi-center clinical trial to evaluate HeartWare VAD for destination therapy — Co-PI — 5% effort — 2010–2012

Biogen-IDEC — BALANCE STUDY: Treatment of hyponatremia based on Lixivaptan in NYHA Class III/IV cardiac patient evaluation — Co-PI — 5% effort — 2008–2009

BioHeart, Inc. — MARVEL: Phase II/III, double-blind, randomized, controlled, multicenter study to assess safety and cardiovascular effects of Myocell implantation in congestive heart failure patients post MI — Co-PI — 5% effort — 2007–2009

Novartis Pharmaceuticals — Randomized, double-blind, placebo-controlled study of tyrosine kinase inhibitor STI571 for treatment of pulmonary arterial hypertension (Investigator-Initiated Trial) — Co-PI — 5% effort — 2007–2008

Astellas Pharmaceuticals — Intravascular Ultrasound Findings from the TICTAC Trial — PI — 5% effort — 2008–2009

Cotherix — Inhaled Iloprost to Reduce Pulmonary Vascular Resistance in Heart Failure Patients Undergoing Routine Right Heart Catheterization (Investigator-Initiated Trial) — PI — 5% effort — 2005–2007

Impulse Dynamics — FIX-HF-5 Trial (Implantable Cardiac Contractility Modulation Device for Advanced Heart Failure) — PI — 5% effort — 2005–2007

Arginox Pharmaceuticals — TRIUMPH Trial (Tilarginine in Cardiogenic Shock Complicating Acute Myocardial Infarction) — PI — 5% effort — 2005–2007

Novartis Pharmaceuticals — Protocol CRAD001A2403: Neoral in Combination with Everolimus in De Novo Heart Transplant Recipients — Co-PI — 5% effort — 2004–2006

Novacardia — Effects of KW-3902 on Diuresis and Renal Function in Congestive Heart Failure Patients (Protocol CKI-202) — Co-PI — 5% effort — 2004–2006

Scios Pharmaceuticals — A Retrospective Review of Combination Use of Nesiritide With Inotropic Agents (Investigator-Initiated Study) — PI — 5% effort — $15,000 direct — 2003–2005

Astellas Pharmaceuticals — TICTAC Trial: A Randomized Comparison of Tacrolimus and Mycophenolate Mofetil Versus Tacrolimus Alone In Steroid-Free Cardiac Transplant Recipients (single-center investigator-initiated) — PI — 10% effort — $226,000 direct — 2004–2009

Scios Pharmaceuticals — FUSION-2 Trial (Intermittent Nesiritide for Heart Failure Patients) — PI — 5% effort — 2004–2007

National Institutes of Health — SHOCK-2 Randomized Clinical Trial (Should We Use Nitric Oxide Inhibition in Cardiogenic Shock) — Local PI — 5% effort — 2003–2004

National Institutes of Health — Clinical Research Loan Repayment Grant (CR-LRP) — Loan repayment grant based on career in clinical research — 5% effort — $100,000 direct — 2003–2008 (renewed once)

Bibliography

Peer-Reviewed Articles

• Skelton WP 3rd, Baran DA, Skelton NK. Hyperpyrexia as the Sole Symptom of Thyrotoxicosis. South Med J 1991;84:1510.
• Sinnott JT, Oehler RL, Baran DA. Relapsing Fever: Ticked Off By A Lousy Illness. Infections in Medicine January 1993.
• Holt DA, Baran DA, Oehler RL, Sinnott JT. Delta Hepatitis: A Diagnostic Algorithm. Infections in Medicine June 1993.
• Baran D, Ogino K, Stennett R, Schnellbacher M, Zwas D, Morgan JP, Burkhoff D. Interrelating Of Ventricular Pressure And Intracellular Calcium In Intact Hearts. Am J Physiol 1997;273:H1509-22.
• Baran D, Horn EM, Hryniewicz K, Katz SD. Effects of Beta-Blockers on Neurohormonal Activation in Patients with Congestive Heart Failure. Drugs 2000;60:997-1016.
• Baran DA, Segura L, Kushwaha S, Courtney M, Correa R, Fallon JT, Cheng J, Lansman SL, Gass AL. Tacrolimus Monotherapy In Adult Cardiac Transplant Recipients: Intermediate-Term Results. J Heart Lung Transplant 2001;20:59-70.
• Baran DA, Rosenwinkel E, Spierer DK, Lisker J, Whelan J, Rosa M, Goldsmith RL. Validating Facemask Use for Gas Exchange Analysis in Patients with Congestive Heart Failure. J Cardiopulm Rehabil 2001;21:94-100.
• Gomberg-Maitland M, Baran DA, Fuster V. Treatment of Congestive Heart Failure: Guidelines for the Primary Care Physician and the Heart Failure Specialist. Arch Intern Med 2001;161:342-52.
• Baran DA, Galin ID, Sandler D, Segura L, Correa R, Courtney MC, Cheng J, Chan M, Lansman SL, Spielvogel D, Fallon JT, Gass AL. A Novel Tacrolimus Dosing Strategy in Cardiac Transplantation: Drug Levels, Renal Function, and Biopsy Results. Transplant Proc 2002;34:1834-5.
• Baran DA, Ashkar J, Galin ID, Sandler D, Segura L, Courtney MC, Correa R, Chan M, Lansman SL, Spielvogel D, Cheng J, Gass AL. Tacrolimus And New Onset Diabetes Mellitus: The Effect Of Steroid Weaning. Transplant Proc 2002;34:1711-2.
• Baran DA, Galin ID, Sandler D, Cheng J, Segura L, Courtney MC, Correa R, Chan M, Lansman SL, Spielvogel D, Gass AL. Predictors Of Early Renal Insufficiency In Cardiac Transplant Recipients Initiated On Tacrolimus. Transplant Proc 2002;34:1872-3.
• Baran DA, Galin ID, Segura L, Courtney MC, Correa R, Lansman SL, Spielvogel D, Ashkar J, Cheng J, Fallon JT, Gass AL. Tacrolimus And Cardiac Transplantation: A Comparison Of Monotherapy And Steroid-Dependent Patients. Transplant Proc 2002;34:1845-6.
• Baran DA, Galin ID, Gass AL. Current Practices: Immunosuppression Induction, Maintenance, and Rejection Regimens in Contemporary Post-Heart Transplant Patient Treatment. Curr Opin Cardiol 2002;17:165-70.
• Baran DA, Gomberg-Maitland M. CHF in the ICU: The Diagnostic Challenge. Journal of Critical Illness October 2002.
• Baran DA, Gomberg-Maitland M. CHF in the ICU: The Treatment Challenge. Journal of Critical Illness November 2002.
• Galin I, Baran DA. Congestive Heart Failure: Guidelines for the Primary Care Physician. Mt Sinai J Med 2003;70:251-64.
• Baran DA, Galin ID, Gass AL. Calcineurin Inhibitor-Associated Early Renal Insufficiency in Cardiac Transplant Recipients: Risk Factors and Strategies for Prevention and Treatment. Am J Cardiovasc Drugs 2004;4:21-9.
• Baran DA, Galin I, Sandler D, Segura L, Cheng J, Courtney MC, Correa R, Chan M, Fallon JT, Spielvogel D, Lansman SL, Gass AL. Tacrolimus In Cardiac Transplantation: Efficacy And Safety Of A Novel Dosing Protocol. Transplantation 2002;74:1136-41.
• Baran DA, Galin ID, Courtney MC, Correa R, Chan M, Spielvogel D, Lansman SL, Gass AL. Cardiac Transplantation In The Older Recipient: Excellent Long-Term Survival Based On Pretransplant Screening. Transplant Proc 2003;35:2465-7.
• Baran DA, Galin ID. "One Size Fits All": Immunosuppression In Cardiac Transplantation. Ann Transplant 2003;8:7-9.
• Strauch JT, Spielvogel D, Haldenwang PL, Correa RK, DeAsla RA, Seissler PE, Baran DA, Gass AL, Lansman SL. Recent Improvements in Outcome with the Novacor Left Ventricular Assist Device. J Heart Lung Transplant 2003;22:674-80.
• Spierer DK, Goldsmith R, Baran DA, Hryniewicz K, Katz SD. Effects Of Active Vs. Passive Recovery On Work Performed During Serial Supramaximal Exercise Tests. Int J Sports Med 2004;25:109-14.
• Baran DA, Galin ID, Zucker MJ, Alvi S, Arroyo LH, Lubitz S, Kaplan S, Correa R, Courtney MC, Chan M, Spielvogel D, Lansman SL, Gass AL. Can Initial Tacrolimus Trough Levels Be Predicted From Clinical Variables? Transplant Proc 2004;36:2816-8.
• Bishburg E, Zucker MJ, Baran DA, Arroyo LH. Mycobacterium Xenopi Infection after Heart Transplantation: An Unreported Pathogen. Transplant Proc 2004;36:2834-6.
• Gordon RY, Fallon JT, Baran DA. Case Report: A 32-Year-Old Woman with Familial Paragangliomas and Acute Cardiomyopathy. Transplant Proc 2004;36:2819-22.
• Lubitz S, Baran DA, Fallon JT, Gass AL. Case Report: Treatment of Refractory Humoral Rejection with a Single Dose of Rituximab. Transplant Proc 2004;36:3164-6.
• Goldstein DJ, Zucker MJ, Arroyo LH, Baran DA, McCarthy P, Loebe M, Noon G. Safety And Feasibility Trial Of The Micromed Debakey Ventricular Assist Device As A Bridge To Transplantation. J Am Coll Cardiol 2005;45:962-3.
• Zucker MJ, Baran DA, Arroyo LH, Goldstein DJ, Neacy C, Mele L, Weinberg AD, Prendergast TW, Ribner HS. De Novo Immunosuppression With Sirolimus And Tacrolimus In Heart Transplant Recipients Compared With Cyclosporine And Mycophenolate Mofetil — A One Year Follow-Up Analysis. Transplant Proc 2005;37:2231-9.
• Baran DA, Gass AL, Galin ID, Zucker MJ, Arroyo LH, Goldstein DJ, Prendergast T, Lubitz S, Courtney MC, Correa R, Chan M, Spielvogel D, Lansman SL. Lack Of Sensitization And Equivalent Post-Transplant Outcomes With The Novacor Left Ventricular Assist Device. J Heart Lung Transplant 2005;24:1886-90.
• Lubitz SA, Baran DA, Alwarshetty MM, Pinney S, Kaplan S, Chan M, Courtney MC, Lansman SL, Spielvogel D, Gass AL. Long-Term Results Of Tacrolimus Monotherapy In Cardiac Transplant Recipients. J Heart Lung Transplant 2006;25:699-706.
• Lubitz SA, Baran DA, Alwarshetty MM, Zucker MJ, Arroyo LH, Chan M, Courtney MC, Correa R, Spielvogel D, Lansman SL, Gass AL. Improved Survival With Statins, Angiotensin Receptor Blockers, And Steroid Weaning After Heart Transplantation. Transplant Proc 2006;38:1501-6.
• Baran DA, Alwarshetty MM, Alvi S, Arroyo LH, Lubitz S, Pinney S, Gass AL, Zucker MJ. Is Toxoplasmosis Prophylaxis Necessary In Cardiac Transplantation? Long-Term Follow-Up at Two Transplant Centers. J Heart Lung Transplant 2006;25:1380-2.
• Lubitz SA, Pinney S, Wisnivesky JP, Gass A, Baran DA. Statin Therapy Associated With A Reduced Risk Of Chronic Renal Failure After Cardiac Transplantation. J Heart Lung Transplant 2007;26:264-72.
• Dzavik V, Cotter G, Reynolds HR, Alexander JH, Ramanathan K, Stebbins AL, Hathaway D, Farkouh ME, Ohman EM, Baran DA, et al. Effect of Nitric Oxide Synthase Inhibition on Haemodynamics and Outcome of Patients with Persistent Cardiogenic Shock Complicating Acute Myocardial Infarction: A Phase II Dose-Ranging Study. Eur Heart J 2007;28:1109-16.
• Baran DA. Induction Therapy in Cardiac Transplantation: When and Why? Heart Fail Clin 2007;3:31-41.
• Baran DA, Zucker MJ, Arroyo LH, Alwarshetty MM, Ramirez MR, Prendergast TW, Goldstein DJ, Camacho M, Gass AL, Carr C, Cohen M. Randomized Trial Of Tacrolimus Monotherapy: Tacrolimus In Combination, Tacrolimus Alone Compared (The TICTAC Trial). J Heart Lung Transplant 2007;26:992-7.
• Sabnani I, Zucker MJ, Rosenstein ED, Baran DA, Arroyo LH, Tsang P, Zubair M, Rivera V. A Novel Therapeutic Approach to the Treatment of Scleroderma-Associated Pulmonary Complications: Safety and Efficacy of Combination Therapy with Imatinib and Cyclophosphamide. Rheumatology (Oxford) 2009;48:49-52.
• Abraham WT, Burkhoff D, Nademanee K, Carson P, Bourge R, Ellenbogen KA, Parides M, Kadish A; FIX-HF-5 Investigators. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation in Patients with Systolic Heart Failure: Rationale, Design, and Baseline Patient Characteristics. Am Heart J 2008;156:641-648.
• Shah M, Bishburg E, Baran DA, Chan T. Epidemiology and Outcomes of Clostridial Bacteremia at a Tertiary-Care Institution. Scientific World Journal 2009;9:144-8.
• Baran DA, Martin T, Blicharz D, Carr C, Zucker MJ, McBride L, Camacho M. Simple Method To Eliminate Interference Between Ventricular Assist Devices And Cardiac Rhythm Devices. Pacing Clin Electrophysiol 2009;32:1142-5.
• Zucker MJ, Sabnani I, Baran DA, Balasubramanian S, Camacho M. Cardiac Transplantation And/Or Mechanical Circulatory Support Device Placement Using Heparin Anti-Coagulation In The Presence Of Acute Heparin-Induced Thrombocytopenia. J Heart Lung Transplant 2009 Oct 8.
• Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Elashoff B, Baron H, Yee J, Valantine HA; IMAGE Study Group. Gene-Expression Profiling For Rejection Surveillance after Cardiac Transplantation. N Engl J Med 2010;362:1890-900.
• Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al.; International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the Care of Heart Transplant Recipients. J Heart Lung Transplant 2010;29:914-56.
• Baran DA, Zucker MJ, Arroyo LH, Camacho M, Goldschmidt ME, Nicholls SJ, et al. A Prospective, Randomized Trial of Single Versus Dual Drug Immunosuppression in Heart Transplantation: The Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC) Trial. Circ Heart Fail 2011 Jan 7.
• Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al.; Consensus Conference Participants. Report from a Consensus Conference on Antibody-Mediated Rejection in Heart Transplantation. J Heart Lung Transplant 2011;30:252-69.
• Abraham WT, Nademanee K, Volosin K, et al.; FIX-HF-5 Investigators. Subgroup Analysis Of A Randomized Controlled Trial Evaluating The Safety and Efficacy Of Cardiac Contractility Modulation in Advanced Heart Failure. J Card Fail 2011;17:710-7.
• Esquitin R, Razzouk L, Peterson GE, Wright JT Jr, Phillips RA, De Backer TL, Baran DA, et al. Left Ventricular Hypertrophy by Electrocardiography and Echocardiography in the African American Study of Kidney Disease Cohort Study. J Am Soc Hypertens 2012;6:193-200.
• Badesch DB, Feldman J, Keogh A, Mathier MA, Oudiz RJ, Shapiro S, Farber HW, et al.; ARIES-3 Study Group. ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension. Cardiovasc Ther 2012;30:93-9.
• Farkouh ME, Reiffel J, Dressler O, Nikolsky E, Parise H, Cristea E, Baran DA, et al. Relationship between ST-Segment Recovery and Clinical Outcomes after Primary Percutaneous Coronary Intervention: The HORIZONS-AMI ECG Substudy Report. Circ Cardiovasc Interv 2013;6:216-23.
• Baran DA. New Directions in Immunosuppression after Heart Transplantation. Nat Rev Cardiol 2013;10:422-7.
• Van Diepen S, Reynolds HR, Stebbins A, Lopes RD, Džavík V, Ruzyllo W, et al. Incidence And Outcomes Associated With Early Heart Failure Pharmacotherapy In Patients With Ongoing Cardiogenic Shock. Crit Care Med 2014;42:281-8.
• Deng MC, Elashoff B, Pham MX, et al.; IMAGE Study Group. Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients. Transplantation 2014;97:708-14.
• Tayal R, Pieretti J, Baran DA. Severe Systemic Vasospasm Causing Recurrent Cardiac Arrest after Orthotopic Heart Transplantation. J Heart Lung Transplant 2013;32:1271-2.
• Baran DA, Jaiswal A. Management of the ACC/AHA Stage D Patient: Mechanical Circulatory Support. Cardiol Clin 2014;32:113-24.
• Baran DA. The Courage to Push: Donors and Recipients. J Heart Lung Transplant 2014;33:139-40.
• Neragi-Miandoab S, Baran D, Godelman A, Goldstein DJ. Orthotopic Heart Transplantation in Patients with Persistent Left Superior Vena Cava: Bicaval and Biatrial Techniques. Ann Thorac Surg 2014;97:1085-7.
• Kobashigawa J, Zuckermann A, Macdonald P, et al.; Consensus Conference Participants. Report from a Consensus Conference on Primary Graft Dysfunction after Cardiac Transplantation. J Heart Lung Transplant 2014;33:327-40.
• Russo MJ, Gidea C, Karanam R, Baran DA, Saunders CR, Zucker MJ, Camacho MT. Successful Management of Thrombosis of the Proximal Aorta after Implantation with a Biventricular Assist Device. J Extra Corpor Technol 2014;46:310-3.
• Jaiswal A, Sabnani I, Baran DA, Zucker MJ. A Unique Case of Rituximab-Related Posterior Reversible Encephalopathy Syndrome in a Heart Transplant Recipient with Posttransplant Lymphoproliferative Disorder. Am J Transplant 2015;15:823-6.
• Khush KK, Pham MX, Teuteberg JJ, et al.; IMAGE Study Group. Gene Expression Profiling To Study Racial Differences after Heart Transplantation. J Heart Lung Transplant 2015 Feb 7.
• Starling RC, Stehlik J, Baran DA, Armstrong B, Stone JR, Ikle D, et al.; CTOT-05 Consortium. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant 2016;16:121-36.
• Baran DA, Hernandez-Montfort JA, Dhesi P. Meeting Update: International Society for Heart and Lung Transplantation 2014. Kardiochir Torakochirurgia Pol 2015;12:37-41.
• Ardehali A, Esmailian F, Deng M, et al.; PROCEED II Trial Investigators. Ex-Vivo Perfusion Of Donor Hearts For Human Heart Transplantation (PROCEED II): A Prospective, Open-Label, Multicenter, Randomized Non-Inferiority Trial. Lancet 2015;385:2577-84.
• Wang L, Zucker MJ, Cohen M, Baran DA, Camacho M, Gidea C, et al. Pre-Operative Speckle-Tracking Imaging To Predict The Need For Right Ventricular Support In Patients Undergoing LVAD Implantation. Journal of Cardiovascular Disease Research 2015;6(1).
• Ware JS, Li J, Mazaika E, et al.; IMAC-2 and IPAC Investigators. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med 2016;374:233-41.
• Mehra MR, Canter CE, Hannan MM, et al.; ISHLT Infectious Diseases, Pediatric and Heart Failure and Transplantation Councils. The 2016 ISHLT Listing Criteria for Heart Transplantation: A 10-year Update. J Heart Lung Transplant 2016;35:1-23.
• Visveswaran GK, Gidea C, Baran D, Cohen M, Zucker MJ. Acute Left Ventricular Dysfunction Complicating Pregnancy On ECMO: Tri-Iodothyronine To The Rescue With Real Time Transesophageal Echocardiography. Journal of Cardiology Cases 2016;13:33-36.
• Visveswaran GK, Cohen M, Seliem A, DiVita M, McNamara JK, Dave A, Wasty N, Baran DA. A Single Center Tertiary Care Experience Utilizing the Large Volume Mega 50cc Intra-Aortic Balloon Counterpulsation in Contemporary Clinical Practice. Catheter Cardiovasc Interv 2017 Feb 1.
• Kobashigawa J, Khush K, Colvin M, Acker M, Van Bakel A, Eisen H, Naka Y, Patel J, Baran DA, et al. Report From The American Society Of Transplantation Conference On Donor Heart Selection In Adult Cardiac Transplantation In The U.S. Am J Transplant 2017;17:2559-2566.
• Baran DA. Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient. Curr Transplant Rep 2017;4:218-225.
• Chauhan D, Okoh AK, Haik N, Kang N, Choi M, Baran D, Zucker M, Camacho M, Russo MJ. The Effect of Continuous-Flow Left Ventricular Assist Device Duration on Post-Operative Outcomes. Ann Thorac Surg 2017;104:1933-1938.
• Chauhan D, Okoh AK, Fugar S, Karanam R, Baran D, Zucker M, Camacho M, Russo MJ. Impact Of Left-Ventricular Assist Device-Related Complications on Post-Transplant Graft Survival. Ann Thorac Surg 2017;104:1947-1952.
• McTiernan CF, Morel P, Cooper LT, Rajagopalan N, Thohan V, Zucker M, et al.; IPAC Investigators. Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study. J Card Fail 2018;24:33-42.
• Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT. Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J 2018;64:570-572.
• Baran DA, Visveswaran GK, Seliem A, DiVita M, Wasty N, Cohen M. Differential Responses to Larger Volume Intra-Aortic Balloon Counterpulsation: Hemodynamic and Clinical Outcomes. Catheter Cardiovasc Interv 2018;92:703-710.
• Baran DA, Rosenfeld C, Zucker MJ. Corticosteroid Weaning in Stable Heart Transplant Patients: Guidance by Serum Cortisol Level. J Transplant 2018;2018:3740395.
• Mulukutla SR, Babb JD, Baran DA, et al. A Quality Framework for the Role of Invasive, Non-Interventional Cardiologists in the Present-Day Cardiac Catheterization Laboratory: A Multidisciplinary SCAI/HFSA Expert Consensus Statement. Catheter Cardiovasc Interv 2018;92:1356-1364.
• Baran DA, Stelling K, McQueen D, Pearson M, Shah V. Pediatric Veno-Veno Extracorporeal Membrane Oxygenation Rescue From Carbon Monoxide Poisoning. Pediatr Emerg Care 2018 Apr 25.
• Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, et al.; ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 2018;379:1007-1016.
• Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, et al. Early Immune Biomarkers and Intermediate-Term Outcomes after Heart Transplantation: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant 2018 Dec 14.
• Carter KT, Lirette ST, Baran DA, Creswell LL, Panos AL, Cochran RP, Copeland JG, Copeland H. The Effect of Cardiac Preservation Solutions on Heart Transplant Survival. J Surg Res 2019;242:157-165.
• Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI Clinical Expert Consensus Statement on the Classification of Cardiogenic Shock. Catheter Cardiovasc Interv 2019;94:29-37.
• Baran DA, Copeland H, Copeland J. What Number Are We? Circ Heart Fail 2019;12:e005823.
• Koczo A, Marino A, Jeyabalan A, et al.; IPAC Investigators. Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy. JACC Basic Transl Sci 2019;4:291-300.
• Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, et al. Initial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus Guidelines. Transpl Int 2019 Sep 10.
• Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. J Am Coll Cardiol 2019 Sep 17.
• Jentzer JC, Baran DA, van Diepen S, Barsness GW, Henry TD, Naidu SS, Bell MR, Holmes DR Jr. Admission SCAI Shock Stage Stratifies Post-Discharge Mortality Risk in Cardiac Intensive Care Unit Patients. Am Heart J 2020;219:37-46.
• Harhash AA, Cassuto J, Hussein A, Achu E, Zucker MJ, Goldschmidt M, Alpert JS, Baran DA. Safety of Outpatient Milrinone Infusion in End Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias. Am J Med 2019 Dec 26.
• van Diepen S, Baran DA, Mebazaa A. What Is the Role of Medical Therapy in Cardiogenic Shock in the Era of Mechanical Circulatory Support? Can J Cardiol 2019 Nov 30.
• Baran DA, Rao P, Deo D, Zucker MJ. Differential Gene Expression in Non-Adherent Heart Transplant Survivors: Implications for Regulatory T-Cell Expression. Clin Transplant 2020;34:e13834.
• Jentzer JC, Henry TD, Barsness GW, Menon V, Baran DA, Van Diepen S. Influence of Cardiac Arrest and SCAI Shock Stage on Cardiac Intensive Care Unit Mortality. Catheter Cardiovasc Interv 2020;10.1002/ccd.28854.
• Hanson ID, Tagami T, Mando R, et al.; National Cardiogenic Shock Investigators. SCAI Shock Classification in Acute Myocardial Infarction: Insights from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv 2020;10.1002/ccd.29139.
• Long A, Yehya A, Baran DA. Lactate Dehydrogenase Rising: Bleeding or Clotting? The VAD Journal 2020;6(1):Article 9.
• Tayal R, DiVita M, Sossou CW, Okoh AK, Stelling K, McCabe JM, Kaki A, Wasty N, Baran DA. Efficacy of Manual Hemostasis for Percutaneous Axillary Artery Intra-Aortic Balloon Pump Removal. J Interv Cardiol 2020;2020:8375878.
• Barbagelata A, Giorgi J, Koerner MM, Baran DA. Multiorgan failure during COVID-19 pandemic in cardiovascular patients: Role of advanced cardiac and pulmonary support. Revista Argentina de Cardioangiología Intervencionista 2020;11:58-64.
• Carter KT, O'Brien R, Larson SB, Creswell LL, Kutcher M, Baran DA, Copeland JG, Copeland H. Veno-Arterial Extracorporeal Membrane Oxygenation is a Viable Option as a Bridge to Heart Transplant. J Thorac Cardiovasc Surg 2020.
• Padkins M, Breen T, Anavekar N, et al. Age and Shock Severity Predict Mortality in Cardiac Intensive Care Unit Patients with and without Heart Failure. ESC Heart Fail 2020 Sep 10.
• Cochrane AB, Lyster H, Lindenfeld J, et al. Report from the 2018 Consensus Conference on Immunomodulating Agents in Thoracic Transplantation. J Heart Lung Transplant 2020;39:1050-1069.
• Baran DA, Long A, Badiye AP, Stelling K. Prospective Validation of the SCAI Shock Classification: Single Center Analysis. Catheter Cardiovasc Interv 2020;96:1339-1347.
• Shaw TB, Lirette S, Carter KT, Kutcher ME, Baran DA, Copeland JG, Copeland H. Does Pediatric Heart Transplant Survival Differ with Various Cardiac Preservation Solutions? Clin Transplant 2020:e14122.
• Baran DA, Long A, Jentzer JC. The Stages of CS: Clinical and Translational Update. Curr Heart Fail Rep 2020;17:333-340.
• Riddle M, McCallum R, Ojha CP, Paul TK, Gupta V, Baran DA, et al. Advances in the Management of Atrial Fibrillation with a Special Focus on Non-Pharmacological Approaches to Prevent Thromboembolism. J Investig Med 2020;68:1317-1333.
• Jentzer JC, Lawler PR, van Diepen S, Henry TD, Menon V, Baran DA, et al. Systemic Inflammatory Response Syndrome Is Associated with Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients. Circ Cardiovasc Qual Outcomes 2020 Dec 7.
• Wilson TJ, Baran DA, Herre JM, Cameron CM, Yehya A, Ingemi AI. Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization. ASAIO J 2020 Dec 18.
• Jentzer JC, Burstein B, Van Diepen S, Murphy J, Holmes DR Jr, Bell MR, et al. Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients. Circ Heart Fail 2021;14:e007678.
• Carter KT, Lirette ST, Baran DA, Creswell L, Kutcher ME, Copeland JG, Copeland H. The Effects of Increased Donor Support Time from Organ Donation Referral to Donor Procurement on Heart Transplant Recipient Survival. J Card Surg 2021 Feb 22.
• Tyler JM, Brown C, Jentzer JC, Baran DA, van Diepen S, Kapur NK, et al. Variability in Reporting of Key Outcome Predictors in Acute Myocardial Infarction Cardiogenic Shock Trials. Catheter Cardiovasc Interv 2021 Apr 19.
• Jentzer JC, Kashani KB, Wiley BM, Patel PC, Baran DA, Barsness GW, et al. Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock. Shock 2021 May 13.
• Jentzer JC, van Diepen S, Henry TD, Baran DA, Barsness GW, Holmes DR Jr. Influence of Intra-Aortic Balloon Pump on Mortality as a Function of Cardiogenic Shock Severity. Catheter Cardiovasc Interv 2021 May 28.
• Arrigo M, Price S, Baran DA, Pöss J, Aissaoui N, et al. Optimising Clinical Trials in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Statement from the 2020 Critical Care Clinical Trialists Workshop. Lancet Respir Med 2021 Jul 7.
• Baran DA, Lansinger J, Long A, Herre JM, Yehya A, Sawey EJ, et al. Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety. Circ Heart Fail 2021 Jul 28.
• Long A, Stelling K, Baran DA. Pop the Balloon: Rapid Switch from Intra-Aortic Balloon Pump to Alternate Device. Clin Case Rep 2021;9:e04614.
• Jaiswal A, Gadela NV, Baran D, Balakumaran K, Scatola A, et al. Clinical Outcomes of Older Adults Listed for Heart Transplantation in the United States. J Am Geriatr Soc 2021;69:2507-2517.
• Freund A, Pöss J, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, et al. Comparison of Risk Prediction Models in Infarct-Related Cardiogenic Shock. Eur Heart J Acute Cardiovasc Care 2021 Sep 16.
• Cockrell HC, O'Brien R, Carter KT, Shaw TB, Baran DA, et al. Better Together: A Reappraisal of Heterotopic Heart Transplantation. Transpl Int 2021 Sep 25.
• Jaiswal A, Gadela NV, Baran DA, Dasgupta O, Gluck J, et al. Post Heart Transplantation Outcomes of Patients Supported on Biventricular Mechanical Support. ASAIO J 2021 Oct 5.
• Long A, Baran DA. Lingua Franca of Cardiogenic Shock: Speaking the Same Language. Front Cardiovasc Med 2021;8:691232.
• Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK Stage Classification Expert Consensus Update [endorsed by ACC, ACEP, AHA, ESC ACVC, ISHLT, SCCM, STS]. J Am Coll Cardiol 2022 Jan 28.
• Tehrani BN, Drakos S, Billia F, Batchelor WB, Luk A, Stelling K, et al. The Multicenter Collaborative to Enhance Biologic Understanding, Quality and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design. Can J Cardiol 2022 Mar 11.
• Birk SE, Ingemi A, Bourassa P, Neumann K, Pine C, et al. Protocol-Based Anticoagulation Management for Mechanical Circulatory Support Patients Can Be Safe and Efficient. Int J Artif Organs 2022 Apr 20.
• Baran DA, Jaiswal A, Hennig F, Potapov E. Temporary Mechanical Circulatory Support: Devices, Outcomes, and Future Directions. J Heart Lung Transplant 2022;41:678-691.
• Siddiqi U, Lirette S, Hoang R, Cruz J, Mohammed A, Copeland J, Baran DA, Copeland H. Ischemic Time and Patient Outcomes after the 2018 UNOS Donor Heart Allocation System Change. J Card Surg 2022;37:2685-2690.
• Shaw TB, Blitzer D, Carter KT, Lirette S, Mohammed A, Copeland J, Baran DA, Copeland H. Functional Status of Heart Transplant Recipients Predicts Survival. Clin Transplant 2022;36:e14748.
• Baran DA, Long A, Lansinger J, Copeland JG, Copeland H. Donor Utilization in the Recent Era: Effect of Sex, Drugs, and Increased Risk. Circ Heart Fail 2022;15:e009547.
• Jaiswal A, Baran DA, Sinphurmsukskul S, Baker WL. Cardiac Donors with Renal Impairment: Usage and Outcomes after Heart Transplant. Clin Transplant 2022 Jul 5:e14767.
• Rao PN, Deo DD, Gaur A, Baran DA, Zucker MJ, et al. A New Flow Cytometry Assay Identifies Recipient IgG Subtype Antibodies Binding Donor Cells. Clin Transl Immunology 2022;11:e1415.
• McCune TR, Bray RA, Baran DA, Toepp AJ, Forte SJ, et al. Development of Donor Specific Antibodies after SARS-CoV-2 Vaccination in Kidney and Heart Transplant Recipients. Transpl Immunol 2022;75:101722.
• Jentzer JC, Baran DA, Bohman JK, van Diepen S, Radosevich M, et al. Cardiogenic Shock Severity and Mortality in Patients Receiving Venoarterial ECMO Support. Eur Heart J Acute Cardiovasc Care 2022 Sep 29.
• Lindauer KE, Ingemi AI, McMahon MR, Lichvar A, Baran DA, et al. The Utilization and Safety of Apixaban for Therapeutic Anticoagulation in Heart Transplant Population Requiring Routine Endomyocardial Biopsies. Clin Transplant 2022 Oct 4:e14828.
• Copeland H, Knezevic I, Baran DA, Rao V, Pham M, Gustafsson F, et al. Donor Heart Selection: Evidence-Based Guidelines for Providers. J Heart Lung Transplant 2022 Sep 20.
• Jentzer JC, Rayfield C, Soussi S, Berg DD, Kennedy JN, Sinha SS, Baran DA, et al. Advances in the Staging and Phenotyping of Cardiogenic Shock. JACC Adv 2022;1(4). doi:10.1016/j.jacadv.2022.100120
• Jentzer JC, Rayfield C, Soussi S, Berg DD, Kennedy JN, Sinha SS, Baran DA, et al. Machine Learning Approaches for Phenotyping in Cardiogenic Shock and Critical Illness. JACC Adv 2022;1(4). doi:10.1016/j.jacadv.2022.100126
• Rivera NT, Baran DA. Expanding Heart Transplantation in 2022 and Beyond. Curr Opin Cardiol 2023;38:130-135.
• Nurok M, Nunnally ME, Gill G, O'Connor M, Harper M, et al. A Survey of Intensive Care Unit Models in Cardiothoracic Transplantation at High-Volume Centers. Clin Transplant 2023 Jan 11:e14911.
• DeFilippis EM, Kransdorf EP, Jaiswal A, Zhang X, Patel J, Kobashigawa JA, Baran DA, Kittleson MM. Detection and Management of HLA Sensitization in Candidates for Adult Heart Transplantation. J Heart Lung Transplant 2022 Dec 27.
• Blitzer D, Baran DA, Lirette S, Copeland JG, Copeland H. Does Donor Treatment with Inotropes and/or Vasopressors Impact Post-Transplant Outcomes? Clin Transplant 2023 Jan 17:e14912.
• Jaiswal A, Bell J, DeFilippis EM, Kransdorf EP, Patel J, Kobashigawa JA, Kittleson MM, Baran DA. Assessment and Management of Allosensitization Following Heart Transplant in Adults. J Heart Lung Transplant 2022 Dec 20.
• Copeland H, Baran DA, Morton J, Rodriguez V, Fernandes E, Mohammed A. Veno-Venous ECLS Rescue for a Heart Transplant Recipient with COVID-19: A Case Report. Perfusion 2023 Jan 30.
• Baran DA, Kapoor S, Grewal J, Andries G, Camacho M. Long Term Follow-Up of the TICTAC Trial. J Heart Lung Transplant 2023;42:838-845.
• Blitzer D, Lirette S, Kane L, Copeland JG, Baran DA, Copeland H. Do Vasoactive Medications Impact Donor Hearts Clinical Outcomes in Pediatric Heart Transplantation? Pediatr Transplant 2023;27:e14500.
• Nurok M, Nunnally ME, O'Connor M, Pierson RN 3rd, Baran DA, et al. Guidelines and Principles for the Care of the Cardiothoracic Transplant Patient in the Intensive Care Unit. Clin Transplant 2023 Mar 25:e14978.
• Arrigo M, Blet A, Morley-Smith A, Aissaoui N, Baran DA, et al. Current and Future Trial Design in Refractory Cardiogenic Shock. Eur J Heart Fail 2023 Mar 29.
• Alam A, Baran DA, Doshi H, Van Zyl J, Patlolla S, et al. Safety and Efficacy of ProtekDuo Right Ventricular Assist Device: A Systematic Review. Artif Organs 2023 Apr 3.
• Siddiqi U, Blitzer D, Lirette S, Patel A, Hoang R, Mohammed A, Copeland J, Baran DA, Copeland H. Positive Donor Blood Cultures Are Not Associated with Worse Heart Transplant Survival. Clin Transplant 2023 Apr 16:e14994.
• Birk SE, Baran DA, Campbell R, Herre JM, Sadatsafavi H, Yehya A. Clinical Outcomes of Ventricular Assist Device Support by HIV Infection Status: An STS-Intermacs Analysis. J Heart Lung Transplant 2023 May 3.
• Jentzer JC, Baran DA. The Changing Face of Cardiogenic Shock: Definitions, Epidemiology, and Severity Assessment. Curr Opin Crit Care 2023;29:363-370.
• Lovell JP, Bermea K, Yu J, et al.; IPAC; IMAC2 Investigators. Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways. JACC Heart Fail 2023;11:1231-1242.
• Blitzer D, Pegues JN, Lirette ST, Baran DA, Colvin M, Hayanga A, Copeland H. Do Outcomes for Heart Transplantation Differ Based on Donor and Recipient Race? Clin Transplant 2023 Sep 19:e15137.
• Pearston AP, Ingemi AI, Shaeffer ZA, Cameron CM, Biagi KT, Gobble M, Yehya A, Baran DA. Conversion to Tacrolimus Alone Compared to Full Immunosuppression Following Cardiac Transplantation (TACTFUL). Clin Transplant 2023 Sep 21:e15140.
• Cowger JA, Basir MB, Baran DA, Hayward CS, Rangaswami J, Walton A, et al.; Aortix CRS Pilot Study Investigators. Safety and Performance of the Aortix Device in Acute Decompensated Heart Failure and Cardiorenal Syndrome. JACC Heart Fail 2023 Sep 20.
• Gandhi KD, Moras EC, Niroula S, Lopez PD, Aggarwal D, et al. Left Ventricular Unloading With Impella Versus IABP in Patients With VA-ECMO: A Systematic Review and Meta-Analysis. Am J Cardiol 2023;208:53-59.
• Jentzer JC, Van Diepen S, Patel PC, Henry TD, Morrow DA, Baran DA, Kashani KB. Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients. J Am Heart Assoc 2023;12:e032748.
• Baran DA, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, et al.; Consensus Conference Participants. Consensus Statements from the ISHLT Consensus Conference: Heart Failure-Related Cardiogenic Shock. J Heart Lung Transplant 2024;43:204-216.
• Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, et al. Heart Failure Related Cardiogenic Shock: An ISHLT Consensus Conference Content Summary. J Heart Lung Transplant 2024;43:189-203.
• Blitzer D, Baran DA, Lirette S, Copeland H. Does Lung Procurement and Exposure to Perfadex Impact Heart Transplantation Outcomes? Clin Transplant 2024;38:e15280.
• Blitzer D, Lirette ST, Carter KT, Mohammed A, Baran DA, Copeland H. Adoption of Ride Share Services Associated with Decreased Organ Donor Availability. Curr Probl Surg 2024;61:101460.
• Khush K, Hall S, Kao A, Raval N, Dhingra R, Shah P, Bellumkonda L, Ravichandran A, Van Bakel A, Uriel N, Patel S, Pinney S, DePasquale E, Baran DA, et al. Surveillance with Dual Noninvasive Testing for Acute Cellular Rejection after Heart Transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry. J Heart Lung Transplant 2024 May 15.
• McDonald ML, Manla Y, Sonnino A, Alonso M, Neicheril RK, Sanchez A, et al. Predictors of Developing Renal Dysfunction Following Diagnosis of Transthyretin Cardiac Amyloidosis. Clin Cardiol 2024;47:e24298.
• Aleman R, Napoli F, Jamroz T, Baran DA, Sheffield C, Navia J, Rosenthal RJ, Brozzi NA. The Dual Prevalence of Advanced Degrees of Obesity and Heart Failure: A Study from the National Inpatient Sample Database. Surg Obes Relat Dis 2024 May 9.
• Chavez MA, Anderson M, Kyriakopoulos CP, Scott M, Dranow E, Maneta E, et al. Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circ Heart Fail 2024 Jul 25:e011827.
• Alonso M, Neicheril RK, Manla Y, McDonald ML, Sanchez A, et al. Transthyretin Cardiac Amyloid: Broad Heart Failure Phenotypic Spectrum and Implications for Diagnosis. ESC Heart Fail 2024;11:3649-3655.
• Thornhill R, Blitzer D, Lirette ST, Carter KT, Mohammed A, Baran DA, Copeland H. Impact of Center Volume on the Use of Status 2 Exceptions for Heart Transplantation. Clin Transplant 2024;38:e70007.
• Baran DA. A Personal Perspective on Circulatory Support and Outcomes in Shock: Past, Present, and Future. Can J Cardiol 2025;41:568-572.
• Nersesian G, Jaiswal A, Stein J, Pillai A, de By TMMH, Potapov E, Baran DA. Impact of Left Ventricular Size on Outcomes Following HeartMate 3 LVAD Implantation: Analysis of EUROMACS. ASAIO J 2024 Dec 31.
• Randhawa VK, Baran DA, Kanwar MK, Hernandez-Montfort JA, Sinha SS, Barnett CF, Billia F. The Comparative Epidemiology, Pathophysiology and Management of Cardiogenic Shock Associated With AMI and Advanced Heart Failure. Can J Cardiol 2025;41:573-586.
• Jaiswal A, Baker WL, Pillai A, Kittleson M, Mogga B, Jedeon Z, Chen C, Baran DA. Corticosteroid Use Beyond 1-Year Post Heart Transplantation Is Associated With Worse Outcomes: A Contemporary Analysis of the ISHLT Registry. JHLT Open 2025;8:100214.
• Cheng R, Alvarez Villela M, Masoumi A, Esposito ML, Baran DA, Rommel KP, Fudim M, Mahfoud F, Lansky A, Burkhoff D, Kapur NK. Charting the Course for Careers in Interventional Heart Failure: Training, Challenges, and Future Directions. J Soc Cardiovasc Angiogr Interv 2025;4(3 Part A):102569.
• Parker AM, Bird VG, Bansal S, Kazory A, Given RW, Williams MB, Baran DA. Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF). ASAIO J 2025;71:1006-1012.
• Dilli Babu A, Ali Baig MF, Baran DA, Estep J, Wolinsky D, Rivera NT, et al. Comparative Insights on Inpatient Outcomes in Diastolic Heart Failure with and Without Amyloidosis: A Nationwide Propensity-Matched Analysis. J Cardiovasc Dev Dis 2025;12:190.
• Brozzi N, Napoli F, Aleman R, Mando F, Estep JD, Sheffield CD, Navia JL, Velez M, Snipelisky D, Rivera NT, Baran DA. Shock Stages in Cardiac Surgical Patients: Implications for Post-Cardiotomy Shock and Mortality. JACC Adv 2025;4(8):101975.
• Baldetti L, Gallone G, Cianfanelli L, Frea S, Rietdijk W, De Ferrari GM, Ajello S, Baran DA, et al. Intra-Aortic Balloon Pump in Heart Failure-Related Cardiogenic Shock: A Meta-Analysis of Randomized Clinical Trials. ASAIO J 2025 Sep 3.
• Guerrero ME, Daniels DV, Makkar RR, Thourani VH, Asch FM, Pham M, et al.; ENCIRCLE Trial Executive Committee and Study Investigators. Percutaneous Transcatheter Valve Replacement in Individuals With Mitral Regurgitation Unsuitable for Surgery or TEER: A Prospective, Multicountry, Single-Arm Trial. Lancet 2025;406:2541-2550.
• Chen C, Jedeon Z, Jaiswal A, Baran DA, Etts K, Baker WL. Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1-Year After Adult Heart Transplant. Pharmacotherapy 2025 Nov 11.
• Alkhalaileh F, Duarte G, Baran DA. Thriving Long Term After Heart Transplantation. Can J Cardiol 2025 Nov 17.
• Teuteberg J, Patel S, Baran DA, Shah P, Sayer G, Nguyen AB, et al. Multimodal Molecular Testing Provides Prognostic Value for Heart Transplant Recipients. J Heart Lung Transplant 2025 Nov 24.
• Naidu SS, Nathan S, Basir MB, Baran DA, Marbach JA, Grines CL. SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis, and Call to Action. J Soc Cardiovasc Angiogr Interv 2025;4(11):103996.

Books & Book Chapters

Cardiac Transplant for the Frontline Clinician, in Yehya A, Editor, Heart Failure: What a Non-Heart Failure Specialist Needs to Know (2018)

Univentricular Support for the Right Ventricle, in Barac, Yaron et al, Textbook of Transplantation and Mechanical Support for End Stage Heart and Lung Disease (2020)

Univentricular Support for the Left Ventricle, in Barac, Yaron et al, Textbook of Transplantation and Mechanical Support for End Stage Heart and Lung Disease (2020)

Media Appearances & Coverage / Podcasts

Webcast: Interview by Dr. Gregg Stone, "SCAI Shock Classification," October 28, 2019, New York City, NY

Editorials

• Baran DA, Taylor DO, Kobashigawa JA. Immunosuppression And Heart Transplantation: How Do We Define Success? Am J Transplant 2010;10:205-6.
• Baran DA, Mehra MR. Late-Onset Right Heart Failure after Left Ventricular Assist Device Implant: Quo Vadis? J Heart Lung Transplant 2017;36:26-27.
• Baran DA. Shedding Light on Cardiac Allograft Vasculopathy: OCT to Predict Progression of Disease. JACC Cardiovasc Imaging 2017 Mar 10.
• Baran DA. Pregnancy After Heart Transplant: Not For the Faint of Heart. Transpl Int 2018 Mar 25.
• Baran DA. Rejection: The Emperor's New Clothes. Transpl Int 2020;33:500-502.
• Seto AH, Baran DA. Percutaneous Axillary Access: A Call to Arms. Catheter Cardiovasc Interv 2020;96:1489-1490.
• Baran DA. Better Is the Enemy of Good: Ever-Changing Heart Transplant Allocation. Transplant Direct 2020;7:e645.
• Baran DA, Copeland H. Commentary: COVID-19 Extracorporeal Membrane Oxygenation: A Long Way from Home. J Thorac Cardiovasc Surg 2020 Dec 9.
• Baran DA, Copeland H. Unraveling the Causes of Primary Graft Dysfunction. Transplantation 2021 Apr 23.
• Robertson G, Baran DA, Copeland H. Commentary: In Search of the "Good Candidate" for Mechanical Circulatory Support. J Thorac Cardiovasc Surg 2021 May 7.
• Baran DA. A Deceptively Simple Problem: The Case of Cardiogenic Shock. Eur J Heart Fail 2021 Aug 1.
• Baran DA. How to Save a Life: Ex Vivo Heart Preservation. ASAIO J 2021;67:869-870.
• Copeland H, Baran DA. Predicting the Future: Hepatitis C Donors in Focus. J Heart Lung Transplant 2021 Oct 22.
• Copeland H, Baran D. A Persistent Problem — The Dreaded LVAD Driveline Infection. J Card Surg 2022;37:105-106.
• Baran DA, Schrage B. Cardiogenic Shock: Calling for Backup. Eur Heart J Acute Cardiovasc Care 2022 May 3.
• Baran DA. Replacing the Endomyocardial Biopsy: Easier Said Than Done. Transplantation 2022 Aug 8.
• Brozzi NA, Baran DA, Napoli F. Understanding the Potential Value of Cardiovascular Brain Death Donors to Increase the Heart Donor Pool. J Card Surg 2022 Nov 15.
• Baran DA, Brozzi N. Cardiogenic Shock: Searching for a Better Lifeboat. J Am Heart Assoc 2022;11:e028354.
• Baran DA. Progress and Pitfalls: Lessons From the Jarvik 2000 Trial. ASAIO J 2023;69:183-184.
• Baran DA. Anything But a Biopsy: The Quest for Noninvasive Alternatives in Heart Transplantation. Transplantation 2023 May 5.
• DeFilippis EM, Kransdorf EP, Jaiswal A, Zhang X, Patel J, Kobashigawa JA, Baran DA, Kittleson MM. Reply to Comment on "Detection and Management of HLA Sensitization in Candidates for Adult Heart Transplantation". J Heart Lung Transplant 2023 May 9.
• Bhardwaj A, Baran DA. Biomarkers in HF: How Does the "Weight" Weigh in? J Card Fail 2023;29:1132-1134.
• Baran DA. Heart Transplant: Challenge Accepted. J Am Coll Cardiol 2023;81:2358-2360.
• Alam A, Baran DA. East Meets West: Different Continents, Same Problems! Am J Cardiol 2023;203:520-521.
• Baran DA. Cardiogenic Shock: Lessons From Hurricanes. J Am Coll Cardiol 2023;82:996-998.
• Randhawa VK, Baran DA. Unraveling Heart Failure Cardiogenic Shock Profiles and Pathways. Eur J Heart Fail 2023 Dec 20.
• Baran DA, Snipelisky D. Hard Work and Talent in the Battle Against Heart Failure. JACC Heart Fail 2024;12:1071-1072.
• Jaiswal A, Baran DA. Moving Beyond the Ice Age in Heart Transplant Procurement. Transplantation 2025;109:245-246.
• Jhand A, Baran DA. How Deep Is My Ocean? Defining Decongestion for Patients and Trialists. J Soc Cardiovasc Angiogr Interv 2023;2(6 Part B):101171.
• Lewis A, Baran DA. A Gator in Every Pond: The Ever-Present Risk of Right Ventricular Failure. J Card Fail 2024;30:1285-1286.
• Baran DA, Camargo AL. Cardiogenic Shock: We Didn't Start the Fire. JACC Cardiovasc Interv 2025;18:702-704.

Letters

• Baran DA, Hall S, Cowger J. Everything I Wanted. JACC Heart Fail 2021;9:858-859.
• Baran DA, Hall S, Cowger J. Reply: Humanizing Policies and Allocation Systems: A Need to Refocus on Patient-Centered Care. JACC Heart Fail 2022;10:145.

Abstracts (Selected)

• Schellbaecher M, Baran DA, et al. Interrelating Time Course of Ventricular Pressure Generation and Intracellular Calcium Transient in Intact Hearts. American Heart Association Scientific Sessions, November 1996.
• Baran DA, Ramirez MR, Rosenfeld C, Sedani S, Sharma R, Arroyo LH, et al. Prospective Trial of Corticosteroid Weaning in Stable Heart Transplant Recipients Guided by Morning Cortisol Level. American Heart Association Scientific Sessions, November 15, 2005.
• Lubitz SA, Baran DA, Chan M, Courtney M, Pinney S, Gass A. Statin Therapy Is Associated with a Reduced Risk of Chronic Renal Failure after Cardiac Transplantation. ISHLT, Madrid, Spain, April 8, 2006.
• Lubitz SA, Baran DA, Pinney S, Kaplan S, Chan M, Courtney M, Lansman S, Spielvogel S, Gass A. Long-Term Results of Tacrolimus Monotherapy in Cardiac Transplant Recipients. ISHLT, Madrid, Spain, April 6, 2006.
• Krishnamani R, Baran DA, Alwarshetty MM, Zucker MJ, Arroyo LH, Martin A, et al. Time to Allosensitization Following HeartMate Left Ventricular Assist Device Implantation. ISHLT, Madrid, Spain, April 6, 2006.
• Baran DA, Zucker MJ, Arroyo LH, Alwarshetty MM, Ramirez MR, Pinney S, et al. Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC Trial): A Prospective Randomized Trial of Minimized Immunosuppression in Adult Heart Transplant Recipients. ISHLT, Madrid, Spain, April 8, 2006.
• Baran DA, Alwarshetty MM, Alvi S, Arroyo LH, Lansman SL, Spielvogel S, Pinney S, Gass AL, Zucker MJ. Is Toxoplasmosis Prophylaxis Necessary? A 28 Year Follow-Up at 2 Transplant Centers. ISHLT, Madrid, Spain, April 7, 2006.
• Baran DA, et al. Safety and Efficacy of Inhaled Iloprost via a Disposable Nebulizer in Heart Failure Patients with Elevated Pulmonary Vascular Resistance. American Thoracic Society, San Francisco, May 21, 2007.
• Baran DA, Pillai A, Patil A, Camacho M, Carr C, et al. High Risk Groups in the TICTAC Trial — Evaluation of Allograft Rejection and Survival. J Heart Lung Transplant 2009;28(2S):S175. [ISHLT 29th Annual Meeting, Paris]
• Baran DA, Zucker MJ, Arroyo LH, et al. TICTAC Trial: A Prospective Randomized Trial of Minimized Immunosuppression in Adult Heart Transplant Recipients. J Heart Lung Transplant 2006;25(2S):S125. [ISHLT 26th Annual Meeting]
• Baran DA, Pillai A, Patil A, Carr C, et al. Core Lab Analysis of Intravascular Ultrasound Studies from the TICTAC Trial: Is There a Price To Pay for Monotherapy? J Heart Lung Transplant 2009;28(2S):S302-303. [ISHLT 29th Annual Meeting, Paris]
• Baran DA, Pillai A, Patil A, Pardi S, Rosenfeld C, Camacho M, Zucker MJ. A Prospective Trial of Steroid Discontinuation in Stable Heart Transplant Patients as Guided by Serum Cortisol Measurement. J Heart Lung Transplant 2009;28(2S):S216. [ISHLT 29th Annual Meeting, Paris]
• Baran DA, Galin ID, Correa R, DeAsla RA, et al. Novacor Left Ventricular Assist Bridge to Transplant: No Sensitization or Excess Rejection as Compared to Unsupported Patients. J Heart Lung Transplant 2003;22(1S):S195. [ISHLT 23rd Annual Meeting]
• Baran DA, Kaplan S, Lubitz S, Galin I, et al. Graft Vasculopathy: Comparison of Cyclosporine and Tacrolimus Over 15+ Years. J Heart Lung Transplant 2004;23(2S):S164. [ISHLT 24th Annual Meeting]
• Baran DA, Zucker MJ, Goldschmidt ME, et al. TICTAC Trial: 5 Year Results. J Heart Lung Transplant 2010;29(2S):S49. [ISHLT 30th Annual Meeting]
• Baran DA, Farkouh ME, Reiffel J, et al. Resolution of Pathological Q-waves is Associated With Improved Outcomes After Primary PCI for Acute Myocardial Infarction. Circulation 2009;120:S1070-S1071. [AHA Scientific Sessions]
• Farkouh ME, Nikolsky E, Reiffel J, Dressler O, Baran DA, et al. Correlations Between Reciprocal ST-segment Depression on the Baseline ECG, Angiographic Findings and Clinical Outcomes in STEMI Treated with Primary PCI. Circulation 2009;120:S1071. [AHA Scientific Sessions]
• Razzouk L, Peterson GE, Wright JT, Phillips RA, De Backer TL, Baran DA, et al. Left Ventricular Hypertrophy by Electrocardiography in the African-American Study of Kidney Disease and Hypertension. Circulation 2009;120:S1016. [AHA Scientific Sessions]
• Raju P, Nair R, Fayyaz J, Sharma A, Zubair M, Baran DA, Karetzky M. A New Look at Prevalence of Sleep Apnea in Patients Awaiting Cardiac Transplant. CHEST 2009 Meeting, Published Oct 2009.
• Pardi S, Pillai AM, Zucker MJ, Patil A, Palekar S, Carr C, Prevost-Fernandez J, Camacho M, Baran DA. Heart Transplant Patients with Renal Impairment: The Potential Role of BK Virus. ATC 2009, June 2, 2009.
• Baran DA, Arroyo LH, Hebron J, Carr C, Zucker MJ. Safety and Efficacy of Inhaled Iloprost via a Disposable Nebulizer in Heart Failure Patients with Elevated Pulmonary Vascular Resistance. Circulation 2007;116(Suppl II):333.
• Baran DA, Arroyo LH, Carr C, Cohen M, Camacho M, Zucker MJ. TICTAC Trial: A Prospective Randomized Trial of Minimized Immunosuppression in Adult Heart Transplant Recipients. Circulation 2007;116(Suppl II):541.
• Zucker MJ, Sabnani I, Balasubramanian S, Baran DA, Martin T, Arroyo L, Camacho M. Heparin Induced Thrombocytopenia in Patients with Mechanical Circulatory Support Devices. 1st International Interdisciplinary Conference on Bleeding and Thrombosis in Mechanical Cardiac Support, Austria, May 2008.
• Sabnani I, Zucker MJ, Baran DA, Balasubramanian S, Arroyo L, Camacho M, et al. The Role of Serial Testing of Heparin/PF4 Antibodies in Patients with Mechanical Circulatory Support. 1st International Interdisciplinary Conference on Bleeding and Thrombosis in Mechanical Cardiac Support, Austria, May 2008.
• Studer S, Regala M, Migliore C, et al. A Pilot Observational Study of the Correlation Between Depression and Quality of Life Measured by the CAMPHOR. J Heart Lung Transplant 2011;30(4S):105.
• Yaganti V, Tayal R, Anna M, Amponsah M, Baran D, Zucker M. Correlation between Electrocardiographic and Echocardiographic Changes after LVAD Implantation in Patients with Advanced Heart Failure. Eur Heart J 2011;32(suppl 1):455-56.
• Guerrero-Miranda C, Baran DA, Emmanuel O, Pieretti J, Hochbaum N, et al. Classification of Ventricular Assist Device Infections According to ISHLT Formulation and Device Generation. J Heart Lung Transplant 2012;31(4S):21.
• Baran DA, Guerrero-Miranda C, Pieretti J, Hochbaum N, et al. Long-Term Renal Function in the TICTAC Trial: Outcomes Beyond 5 Years. J Heart Lung Transplant 2012;31(4S):91.
• Baran DA, Guerrero-Miranda C, Pieretti J, et al. Cardiac Transplantation Without Induction Therapy Despite Renal Dysfunction: A Report From the TICTAC Trial. J Heart Lung Transplant 2012;31(4S):225.
• Baran DA, Guerrero-Miranda CY, Weiss JA, Pieretti J, et al. Beyond TICTAC: "Real World Consecutive Patient Cohort Survival." J Heart Lung Transplant 2013;32(4S):114.
• Baran DA, Pieretti J, Gidea CG, et al. Incidence of Allograft Vasculopathy in the TICTAC Trial as Compared to a Real World Cohort. J Heart Lung Transplant 2013;32(4S):26.
• Baran DA, Gidea CG, Pieretti J, et al. Correlates of Long-Term Survival in the TICTAC Trial. J Heart Lung Transplant 2013;32(4S):135.
• Baran DA, Vefali H, Costa V, Guerrero-Miranda JA, et al. Incidence of Malignancy on Tacrolimus Monotherapy Versus Combination Therapy: A Report from the TICTAC Trial. J Heart Lung Transplant 2013;32(4S):40.
• Gilstrap L, Niehaus E, Maurer M, et al. A Multi-Center, International Registry of Cardiac Transplantation for Light Chain (AL) and Transthyretin (TTR) Amyloidosis. Am J Transplant 2013;Vol 13:S5:130. [American Transplant Congress]
• Baran DA, Jaiswal A, Haseeb M, Adzic A, Pieretti J, Gidea C, et al. Safety of the Intravascular Ultrasound in Nearly 900 Cases. J Heart Lung Transplant 2014;33(4S):172.
• Baran DA, Jaiswal A, Adzic A, Pieretti J, Gidea C, et al. Does Sequence Matter? Outcomes of Donors Rejected by Local Centers. J Heart Lung Transplant 2014;33(4S):268.
• David A Baran, Marc Cohen, Gautam K Visveswaran, Michael DiVita, Ahmed Seliem, Amar Dave, Najam Wasty, Jonathan E Swinden. Are All Patients Equal in Response to Intra-Aortic Balloon Counterpulsation? Circulation 2015;132:A13087. [AHA Scientific Sessions]
• Gautam K Visveswaran, Marc Cohen, Michael DiVita, Ahmed Seliem, Amar Dave, Jonathan E Swinden, Najam Wasty, David A Baran. Large Volume Intra-Aortic Balloon Counterpulsation: Efficacy and Safety of the Mega 50cc in 150 Consecutive Patients. Circulation 2015;132:A13081. [AHA Scientific Sessions]
• Wang L, Zucker M, Camacho M, Cohen M, Baran D, Chen C. Pre-Operative Speckle-Tracking Imaging For Prediction of Post-Device Right Ventricular Failure in Patients Undergoing LVAD Implantation. ASE Meeting, Montreal, P.Q., June 2011.
• H. Copeland, V. Garcia, A. Sima, D. Baran, A. Mankind, G. Katlaps, N. Lewis, B. Dharmaj, J. Copeland. Lung Preservation Solution Exposure at Cardiac Procurement Is Associated with Increased Incidence of Coronary Arterial Vasculopathy. American Journal of Transplantation April 2017.
• Baran DA, Liaquat K, Pieretti J, Gidea C, Munagala M, et al. Too Much Information: Interaction of Donor Sequence and Acceptance in the UNOS Database. J Heart Lung Transplant 2016;35(4S):S86.